RhumbLine Advisers’s Humacyte HUMA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$106K Sell
174,549
-3,616
-2% -$3.76K ﹤0.01% 3386
2025
Q4
$171K Buy
178,165
+2,686
+2% +$3.8K ﹤0.01% 3246
2025
Q3
$305K Sell
175,479
-2,144
-1% -$4.2K ﹤0.01% 2982
2025
Q2
$371K Buy
177,623
+60,059
+51% +$115K ﹤0.01% 2864
2025
Q1
$200K Buy
117,564
+3,109
+3% +$11.7K ﹤0.01% 3101
2024
Q4
$578K Buy
114,455
+5,005
+5% +$24.8K ﹤0.01% 2582
2024
Q3
$595K Sell
109,450
-1,469
-1% -$9.69K ﹤0.01% 2585
2024
Q2
$532K Buy
110,919
+51,858
+88% +$270K ﹤0.01% 2636
2024
Q1
$184K Buy
59,061
+2,186
+4% +$7.35K ﹤0.01% 3223
2023
Q4
$162K Buy
56,875
+1,930
+4% +$4.95K ﹤0.01% 3282
2023
Q3
$161K Buy
54,945
+1,433
+3% +$4.74K ﹤0.01% 3270
2023
Q2
$153K Buy
53,512
+4,400
+9% +$15.9K ﹤0.01% 3373
2023
Q1
$152K Sell
49,112
-2,194
-4% -$6.24K ﹤0.01% 2800
2022
Q4
$108K Buy
51,306
+28,522
+125% +$86.6K ﹤0.01% 2895
2022
Q3
$74K Buy
22,784
+1,354
+6% +$5.19K ﹤0.01% 3028
2022
Q2
$69K Buy
+21,430
New +$119K ﹤0.01% 3048

Other funds holding HUMA